Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T20:28:21.964Z.
Calculation as of: 2026-10-06T20:28:21.964Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97452f2638ad5d60f1716ef7360feea6a822b872a50cf44a9ba771f9e60b5836
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Twist Bioscience Corporation
Market Cap
$10.40B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.31B
Free Cash Flow Yield
7.28%
TTM Avg
5.41%
3Y Avg
3.92%
5Y Avg
3.33%
Market Cap
$10.24B
Free Cash Flow Yield
1.19%
TTM Avg
3.36%
3Y Avg
3.04%
5Y Avg
3.04%
Market Cap
$10.19B
Free Cash Flow Yield
2.64%
TTM Avg
2.70%
3Y Avg
3.86%
5Y Avg
6.35%
Market Cap
$10.13B
Free Cash Flow Yield
N/A
TTM Avg
3.41%
3Y Avg
2.72%
5Y Avg
2.30%
Market Cap
$10.72B
Free Cash Flow Yield
7.71%
TTM Avg
7.60%
3Y Avg
6.75%
5Y Avg
5.49%
Market Cap
$10.03B
Free Cash Flow Yield
4.18%
TTM Avg
3.37%
3Y Avg
3.13%
5Y Avg
3.61%
Market Cap
$10.87B
Free Cash Flow Yield
6.74%
TTM Avg
6.85%
3Y Avg
3.82%
5Y Avg
2.59%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 7.28% | 5.41% | 3.92% | 3.33% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | 1.19% | 3.36% | 3.04% | 3.04% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 2.64% | 2.70% | 3.86% | 6.35% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | N/A | 3.41% | 2.72% | 2.30% |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 7.71% | 7.60% | 6.75% | 5.49% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 4.18% | 3.37% | 3.13% | 3.61% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 6.74% | 6.85% | 3.82% | 2.59% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 3.56% | 4.30% | 3.39% | 2.87% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
